sc-announce AT lists.ibiblio.org
Subject: Science Commons Announcements
List archive
[sc-announce] GSK, caBIG give away cancer data to speed research -- Science Commons blog
- From: "Donna Wentworth" <dwentworth AT creativecommons.org>
- To: sc-announce AT lists.ibiblio.org
- Subject: [sc-announce] GSK, caBIG give away cancer data to speed research -- Science Commons blog
- Date: Wed, 25 Jun 2008 09:17:46 -0700
GSK, caBIG give away cancer data to speed research
June 25th, 2008It's no secret that we're fans of the National Cancer Institute's caBIG, the Cancer Biomedical Informatics Grid. So we were thrilled to learn that caBIG, which connects more than 60 NCI centers with a common infrastructure, played a central role this past week in what Wired is calling a "Massive Cancer Information Giveaway." The big prize, provided by GlaxoSmithKline (GSK) and shared freely with cancer researchers via caBIG's platform: genomic profiling data for over 300 cancer cell lines. The lines were derived from a wide variety of tumors, including breast, prostate, lung and ovarian cancers.
Why would a major pharmaceutical company give away information that its researchers painstakingly uncovered? Put simply, if the goal is to speed the translation of data into drugs, it helps significantly to have more researchers looking at the data and identifying leads.
"Cataloging this type of information in a network like caBIG leads to a ready-made body of biologic information that can be mined by all cancer researchers to further everyone's understanding of cancer," explains Dr. Richard Wooster, Director of Translational Medicine Oncology, Research & Development at GlaxoSmithKline, in the company's media release. "In turn, we hope this data will further drive the identification of predictive biomarkers and lead to shorter, more directed clinical trials allowing us to bring drugs more quickly to patients who need them."
Any researcher is free to download the GSK cancer data through caArray. The caArray tool is free and open source.
Science Commons is a strong believer in the utility of a commons-based approach to drug discovery, and this afternoon, John Wilbanks will give a talk at caBIG to discuss how data sharing agreements can help simplify, standardize and automate sharing. We have begun to explore implementing tools such as the CC0 waiver and our machine-readable contracts for transferring materials at caBIG, and we look forward to deepening our involvement with caBIG as its legal and technical infrastructure continues to take shape.
................
Donna Wentworth
Communications Specialist
Science Commons
http://sciencecommons.org
dwentworth AT creativecommons.org
................
- [sc-announce] GSK, caBIG give away cancer data to speed research -- Science Commons blog, Donna Wentworth, 06/25/2008
Archive powered by MHonArc 2.6.24.